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AbstrACt
Objective To undertake a comprehensive assessment 
of the strength of preferences among young people 
for attributes of emerging technologies for testing and 
treatment of asymptomatic chlamydia.
Design Discrete choice experiment (DCE) with sequential 
mixed methods design. A staged approach to selection 
of attributes/levels included two literature reviews, focus 
groups with young people aged 16–24 years (n=21), 
experts’ review (n=13) and narrative synthesis. Cognitive 
testing was undertaken to pilot and adapt the initial 
questionnaire. Online national panel was used for final 
DCE survey to maximise generalisability. Analysis of 
questionnaire responses used multinomial logit models 
and included validity checks.
setting England.
Participants 1230 young people aged 16–24 from a 
national online panel (completion rate 73%).
Outcome measures ORs for service attributes in relation 
to reference levels.
results The strongest attribute influencing preferences 
was chlamydia test accuracy (OR 3.24, 95% CI 3.13 to 
3.36), followed by time to result (OR 1.81, 95% CI 1.71 
to 1.91). Respondents showed a preference for remote 
chlamydia testing options (self-testing, self-sampling and 
postal testing) over attendance at a testing location. For 
accessing treatment following a positive test result, there 
was a general preference for online (OR 1.21, 95% CI 1.15 
to 1.28) versus traditional general practitioner (OR 1.18, 
95% CI 1.12 to 1.24) or pharmacy (OR 1.15, 95% CI 1.10 
to 1.22) over clinic services. For accessing a healthcare 
professional and receipt of antibiotics, there was little 
difference in preferences between options.
Conclusions Both test accuracy and very short intervals 
between testing and results were important factors for 
young people when deciding whether to undergo a routine 
test for asymptomatic chlamydia, with test accuracy being 
more important. These findings should assist technology 
developers, policymakers, commissioners and service 
providers to optimise technology adoption in service 
redesign, although use of an online panel may limit 
generalisability of findings to other populations.
IntrODuCtIOn  
Chlamydia is the most commonly reported 
sexually transmitted infection (STI) in 
England, with young people aged 15–24 
accounting for 63% of diagnoses in 2016.1 
The estimated annual cost of chlamydia 
treatment in 2015 was £249.8 million.2 Unde-
tected infections and reinfections can lead 
to significant adverse health consequences, 
such as pelvic inflammatory disease, ectopic 
pregnancy and infertility, which have an 
impact on National Health Service (NHS) 
costs and health-related quality of life.3 A 
National Chlamydia Screening Programme 
(NCSP) was therefore rolled out in England 
for 16–24 year-olds between 2003 and 2008.4 
strengths and limitations of this study
 ► To our knowledge, this is the first large-scale dis-
crete choice experiment (DCE) study to examine 
the preferences of a geographically representa-
tive national sample of young people for emerging 
technologies designed to improve screening for and 
treatment of asymptomatic chlamydia.
 ► Robust sequential methods were used to select final 
DCE attributes and levels, including two literature 
reviews, focus groups with young people and review 
by expert groups.
 ► An online panel enabled access to the population 
targeted for screening, including young people with 
no personal experience of chlamydia testing and 
treatment.
 ► A limitation of this work is that the literature reviews 
inevitably identified more potential attributes than 
could be included in the DCE.
 ► The use of an online panel may limit generalisabil-
ity of findings to the very small percentage (3%) of 
15–24 year-olds who do not currently access the 
internet, and therefore over-represent the accept-
ability of online care.
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However, despite recent evidence of a reduction in chla-
mydia prevalence in England for 2000–2015, concur-
rent with large-scale population testing,5 and the fact 
that uncomplicated infection is easy to treat with oral 
antibiotics, uptake of screening for chlamydia remains 
low.6 Worryingly, there has also been a decline over the 
last 4 years in the number of local authorities achieving 
the public health outcomes framework indicator of 2300 
diagnoses per 100 000 population.1 Barriers identified 
for young people accessing STI testing and treatment 
services include tangible service attributes, such as loca-
tion of service, and personal or behavioural factors such 
as the stigma associated with attendance, embarrassment, 
fear of being recognised and privacy concerns.7–9 
A range of options are currently available for young 
people to access asymptomatic chlamydia testing and 
treatment services. For testing, options include attending 
a genitourinary medicine (GUM) clinic, testing via 
primary care, for example, pharmacies/general prac-
titioners (GP), or via internet testing services where a 
number of websites offer free self-sampling kits online 
with samples sent to laboratories for analysis and results 
communicated directly to patients. For individuals who 
screen positive, options for accessing antibiotic treat-
ment include attending a GUM/sexual health clinic, GP 
practice or pharmacy. Even though a national screening 
programme exists in England, large geographical varia-
tions exist in testing coverage, from 16% of young people 
tested for chlamydia in the West Midlands region to 
27% in London, and in the proportion of positive cases 
treated.1 10
For many health services, digital technology is now 
widely regarded by policymakers as one approach to 
improve access and reduce costs.11 For chlamydia testing 
and treatment, a range of digital options are available, and 
more technologies are likely to enter the market within 
the next 3–5 years.12 These include point-of-care tests,13 
online postal self-sampling, eSexual health clinics,14 
apps and non-face-to-face consultation methods15 16 and 
self-tests networked through mobile phones.17 Such 
innovations provide an opportunity to redesign current 
chlamydia screening services with the aim of improving 
testing and treatment uptake. However, such service rede-
sign should be based on a sound understanding of the 
preferences of young people as service users for specific 
attributes of such services.
Research specifically measuring young people’s pref-
erences nationally for chlamydia testing and treatment 
service options is lacking. Even for STI testing services 
generally, relatively few studies have used a discrete 
choice experiment (DCE) design to assess preferences 
in the UK population.18–21 In comparison with other 
preference elicitation methods, a DCE can quantify the 
relative importance of different attributes that charac-
terise a new or existing product and/or service, identi-
fying which attributes people prioritise and which they 
may be willing to trade with the view to maximising their 
utility.22 A DCE requires respondents to choose between 
competing scenarios, for example, service options, 
described in terms of a particular attribute (eg, time to 
test result) and a range of levels (eg, 30 min to 14 days) 
and to compare these against an alternative scenario. 
DCE studies are very useful because they allow a direct 
assessment of relative preferences for various existing 
and hypothetical new service configurations or treat-
ment approaches.23
The aim of the present study was to undertake a 
comprehensive assessment of the preferences of young 
people, targeted by the NCSP, for emerging technology 
options for testing and treatment in the context of a 
‘check-up test’ where remote care could be medically 
appropriate.14 To our knowledge, no previous study has 
attempted to disentangle strength of preference for attri-
butes associated with new and emerging options for chla-
mydia screening (such as self-testing) or treatment (such 
as online prescription). Because STI services are ‘open 
access’ and not subject to gatekeeping by referral from 
a clinician, the impact of such disruptive innovations 
will be directly dependent on population preferences. 
Early insight into attributes that could influence whether 
individuals are more likely to use a new testing or treat-
ment pathway should therefore be helpful in informing 
product development and pathway redesign for future 
chlamydia screening service models.24 25
MethODs
This study was conducted using an exploratory sequential 
mixed methods design, adopting recommended stages 
for undertaking a DCE,26 as shown in figure 1. In selecting 
methods to design the questionnaire and conduct the 
DCE, reference was made to the International Society for 
Pharmacoeconomics and Outcomes Research good prac-
tice checklist for conjoint analysis.27
Figure 1 Stages in conducting a discrete choice experiment 
(DCE). 
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Patient and public involvement
Young people (with and without experience of STI 
services) participated in focus groups to inform priori-
ties included in the DCE; in cognitive testing to finalise 
questionnaire design; and in questionnaire completion 
to identify preferences, as described in the Acknowledge-
ments section.
selection of attributes and levels
The attributes and associated levels were determined 
using a four-stage approach.28 More detailed information 
is provided in online supplementary file 1.
Literature reviews
Two literature reviews were undertaken to produce a 
comprehensive list of potential themes and factors that 
might influence young people’s choices. These included: 
(1) a systematic review of the use of stated preference 
studies for STI testing and treatment (PROSPERO Reg: 
CRD42014014862); and (2) a scoping review of other 
research exploring preferences and acceptability of STI 
testing and treatment services.
Focus groups
Focus groups were run with young people aged 16–24 
years (4 groups, 3–7 per group; total n=21) to iden-
tify which themes and factors young people consider 
important when choosing to test for STIs. Convenience 
sampling was used to identify participants. Focus group 
topic guides incorporated typical vignettes of situations 
individuals might encounter. Sessions were recorded, 
transcribed and thematic analysis was performed to 
produce a list of potential attributes and levels.29
Expert groups
Four expert groups were convened (n=13), including 
a range of professionals with expert knowledge of the 
service and technology context. Expert groups were 
asked to review the focus group findings in terms of clin-
ical feasibility and practicality.26
Narrative synthesis
Narrative synthesis30 enabled outputs from the three prior 
stages to be synthesised for each potential attribute. This 
approach was adopted as it offered a clear approach to 
synthesis based on the following stages: (1) identification 
of a checklist of properties against which attributes can be 
considered; (2) tabulation against the checklist; and (3) 
conceptual mapping and triangulation against the check-
list. The final synthesis highlighted a tension between 
young people’s desire to be tested for a wide range of 
STIs irrespective of risk, versus clinical guidelines for 
selective testing of STIs based on population group prev-
alence and risk. The range of STIs presented in the DCE 
was consequently limited to chlamydia. Because focus 
group findings indicated difficulty in understanding 
several dimensions of test performance, test accuracy was 
expressed in terms of the likelihood of a false negative 
result.
Questionnaire design and piloting
A generic pairwise choice with opt-out question was 
selected for the questionnaire design. Respondents were 
presented with a series of choice sets for which there were 
three responses: ‘option A’, ‘option B’ or ‘I would not 
test’. A sample choice set is illustrated in figure 2. The 
questionnaire adopted a main effects design using full 
profiles (all attributes included in the study). While some 
DCEs do include an attribute on economic costs, DCEs 
exploring preferences for STI testing services in England 
have generally excluded cost since the NHS provides 
treatment ‘free at the point of delivery.’20 21 A cost attri-
bute was therefore not included.
The questionnaire was developed using SAS V.9.4 soft-
ware to ensure that the design was D-efficient.27 A full 
factorial design was ruled out in favour of a fractional 
factorial design because a full factorial design would 
have contained 3072 possible alternatives, which would 
have been unmanageable in practice for individuals 
to complete or for a blocked questionnaire format to 
handle.31 The smallest 100% efficient design that could 
be created included 48 choice sets. These were blocked 
(halved) into two questionnaires each with 24 choice sets 
using SAS JMP Pro V.9.2.0. Choice set 1 was repeated as 
choice set 25 in each questionnaire to provide an internal 
validity check.
Three rounds of cognitive testing (n=9) were under-
taken to check respondents’ comprehension of informa-
tion when making choices. Cognitive testing, undertaken 
based on two questionnaires of 24 sets, confirmed that 
a study based on two such questionnaires was accept-
able to participants. Some modifications were made to 
levels where reasons for choice selection demonstrated 
that one level (eg, 8 in 100 false negatives) dominated 
the reason for selection. Cognitive testing also identified 
that implausible combinations (eg, a postal test providing 
Figure 2 Sample choice set from the discrete choice 
experiment.
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a result in 2 hours) impacted on completion of the task, 
while unlikely (but feasible) combinations did not. Only 
implausible combinations were therefore excluded from 
the choice sets. The D-efficiency of the design27 calcu-
lated by SAS JMP Pro V.9.2.0, prior to the removal of 
implausible combinations, was 98.06. The final combi-
nation selected for the questionnaire was the one which 
created no duplicate choices and which provided an 
equal balance of the number of choice sets containing 
overlap between questionnaires.
Respondents were asked to provide sociodemographic 
information, including their age, gender, ethnicity, region 
of residence, sexual preference, relationship status and 
whether they had previously been tested for an STI. An 
introduction to the DCE questionnaire provided back-
ground information and an explanation of the attributes 
and levels. The introduction was included in the cognitive 
testing rounds to check comprehension within the target 
age range. As a result, the text was modified and diagrams 
added to illustrate the chlamydia testing pathways. The 
final phase of testing demonstrated that the number of 
choice sets was acceptable to respondents. The use of 
an online panel also provided completion time data to 
support the internal validity checks, and enabled an accu-
rate record of time taken to complete the survey.
Final attributes and levels selected
The six attributes and 24 levels selected for inclusion in 
the final DCE questionnaire are shown in table 1. More 
detailed information used to explain these attributes and 
levels is provided in online supplementary file 2 (pp 3–7).
Participants and recruitment procedure
Participants were drawn from the general population 
rather than from healthcare settings, thereby providing 
access to young people aged 16–24 years who had not 
previously been tested for an STI. An online national 
panel (YouthSight)32 was used to maximise geograph-
ical reach and generalisability. Ex ante subgroup analysis 
was planned by three age bands (16–18, 19–21, 22–24) 
and by gender (male, female). Where subgroup anal-
ysis is planned, it is recommended that there should be 
a minimum of 200 respondents in each subgroup, so a 
sample size of 1200 was required in our study, 600 per 
questionnaire.33 Consent was obtained online prior to 
questionnaire completion. Participants were offered a 
small reimbursement of one point (equivalent to £1) for 
completion of a survey of up to 20 min in length. Points 
could be exchanged for shopping vouchers.
statistical analyses
The multinomial logit (MNL) model developed by 
McFadden was used for analysing responses; this is 
recognised as the convention for three-response choice 
set studies (‘option A’, ‘option B’ or ‘I would not test’).26 34 
Analysis used STATA V.13 SE with the method and code 
outlined by Ryan et al.23 Analyses presented ORs, 95% CIs 
and coefficients for each attribute level. Variables within 
the MNL model were all treated as categorical variables 
for the analysis. Attribute levels were specified using 
dummy coding, the preferred form of coding where 
ORs are to be calculated. Within the model, the levels 
that were dropped to form the reference levels reflected 
those aligned to a ‘typical’ sexual health clinic pathway 
(summarised in table 2). To test the internal validity of 
questionnaire responses, analyses compared full results 
against: (1) removal of responses where participants 
did not answer the repeated choice set consistently; 
(2) removal of any respondents who took less than the 
minimum time (5 min) observed in cognitive testing to 
complete the questionnaire; and (3) removal of responses 
containing the opt-out question data. Further tests for 
internal consistency and rationality were not included, 
since excluding responses on this basis may be viewed as 
an inappropriate imposition of rationality.35
Demographic characteristics (gender, age and ethnicity) 
of respondents were compared with national census 
Table 1 Summary of attributes and levels included in the study
Attribute A1. How you test
A2. Time 
to result A3. Accuracy
A4. Consultation
method A5. Access to HCP
A6. How you get
antibiotics
 L evel 
  L1 Self-test 30 min 2 in 100 (false 
negative)
Online consultation Phone Post to home
  L2 Self-sample and post 2 hours 5 in 100 (false 
negative)
Pharmacy IM Post to collection point
  L3 Self-sample and pharmacy 7 days GP Email Collect from pharmacy
  L4 Self-sample and education/work 14 days Sexual health clinic Face to face Collect from sexual 
health clinic
  L5 GP practice—sample taken by 
healthcare professional
  L6 Sexual health clinic—sample 
taken by healthcare professional
Full descriptions provided in online supplementary file 2 (pp 3–7).
GP, general practitioner; HCP, healthcare professional; IM, instant messenger.
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data.36 The influence of patient-level characteristics (age, 
sex and STI testing history (yes/no)) on the likelihood 
of not choosing to test was examined. In addition to ex 
ante planned subgroup analyses, if sufficient responses 
were received analysis was also planned to compare: (1) 
respondents who had, or had not, previously tested for an 
STI, and (2) those who indicated their relationship status 
as ‘single’ versus those in a sexual relationship with one 
person.
Trade-off between accuracy and time to result was 
examined by considering the probability of uptake for 
tests with characteristics at the opposite ends of the spec-
trum, that is, ‘lower accuracy (5% false negatives), faster 
time to result (30 min)’ and ‘higher accuracy (2% false 
negatives), longer time to result (14 days)’.
results
In total, 1230 fully completed questionnaires were 
received, the platform analytics showed that 460 people 
had opened the questionnaire but did not complete it, 
providing a completion rate of 73%. No further informa-
tion was available on the demographics of the 460 non-re-
sponders nor any information on the point at which they 
chose to exit the survey, so these people could not be 
included in our analyses. Time to complete the 25 choice 
sets ranged from 1 min 19 s to 30 min 19 s with a median 
time to completion of 7 min 51 s. Demographic charac-
teristics of respondents are summarised in the online 
supplementary file 3 (part 1). Comparing the DCE sample 
to the characteristics of 16–24 year-olds in England indi-
cates that gender, age and ethnicity are broadly in line 
with national population demographics, with a slight 
under-representation of the 16–18 years age group. In 
terms of the geographical residence of participants, the 
sample was broadly in line with the geographical distri-
bution of 16–24 year-olds identified in the Office for 
National Statistics Mid-Year Population Estimates 2015,37 
with the exception of a lower proportion of respondents 
from the East of England.
Internal validity checks showed that, in comparison to 
the full data set, all checks yielded very similar ORs with 
no change in the order of the strength of preference for a 
level within each attribute. Results of the internal validity 
checks are included in the online supplementary file 3 
(part 2).
OR values for the full data set and subgroups analysed 
are presented in table 3 with reference levels (1.00). Anal-
ysis of the trade-off between accuracy and time to result is 
presented in table 4. More detailed DCE results, including 
95% CIs as well as OR values plus coefficients for each 
attribute level for all subgroup analyses, are presented in 
online supplementary file 3 (part 3).
In table 3, looking across all attributes and levels for the 
whole population, participants expressed the strongest 
preference for attribute 1—accuracy of test result (OR 
3.242, 95% CI 3.130 to 3.359). There are also differences 
in the strength of preference between males and females 
for this attribute (OR 2.951, 95% CI 2.807 to 3.101 and 
OR 3.570, 95% CI 3.396 to 3.753, respectively), and 
between those who had previously tested or not tested 
(OR 3.000, 95% CI 2.820 to 3.191 and OR 3.482, 95% CI 
3.331 to 3.640, respectively). Time to result was the attri-
bute showing the next strongest preference across all 
subgroups (OR 1.806, 95% CI 1.711 to 1.906). These 
results are consistent with the logical expectation that 
people will prefer higher accuracy and a shorter waiting 
time. Looking specifically at the trade-off between accu-
racy and time to result, table 4 indicates that participants 
are willing to wait noticeably longer in order to have a test 
result with a lower chance of a false negative result.
When considering how to test, all subgroups demon-
strated a preference for self-testing (OR 1.618, 95% CI 
1.514 to 1.729) over attendance at a sexual health clinic. 
Testing via an outreach service in an educational/
work setting was found to be the least preferred option 
(OR 0.821, 95% CI 0.773 to 0.872). Respondents showed 
a consistent strength of preference for those options that 
do not involve direct contact with healthcare professionals 
(self-testing and postal self-sampling), compared with 
those that do. For consultation and treatment following a 
positive test result, there was a preference for non-sexual 
health clinic pathways with online consultation to access 
treatment (OR 1.212, 95% CI 1.150 to 1.277), treatment 
via general practice (OR 1.183, 95% CI 1.123 to 1.246) 
and treatment via pharmacy (OR 1.158, 95% CI 1.100 to 
1.220) preferred in the full data set. At subgroup level 
(age, gender, testing history and relationship status), 
more variation was found in the preference order for this 
attribute, with the exception of the sexual health clinic 
which was consistently the least preferred option across 
all subgroups (see table 3 and online supplementary file 
3, part 3). Finally, the full data set shows that, if someone 
wants to access a healthcare professional, there was no 
statistically significant preference for instant messenger 
or email access compared with accessing the professional 
face to face. Telephone access to a healthcare professional 
was the least preferred access option (OR 0.949, 95% CI 
0.903 to 0.998), and the only statistically significant result 
when compared with face-to-face access (the reference 
level). There was, similarly, no statistically significant 
difference in preferences for how young people might 
Table 2 Dummy coding reference level
Attribute Reference level
How you test Sexual health clinic
Time to result 7 days
Accuracy 5 in 100 (false negative)
Consultation method Sexual health clinic
Access to HCP Face to face
How you get antibiotics Collect from sexual health clinic
HCP, healthcare professional.
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access antibiotics apart from a slight preference for the 
pharmacy versus sexual health clinic (OR 1.075, 95% CI 
1.018 to 1.134).
DIsCussIOn
Our findings indicate that, based on the levels included in 
the DCE questionnaire, young people are willing to wait 
in order to have a chlamydia screening test result with a 
lower chance of a false negative result. The conclusion for 
new test developers is that time to result is less important 
than accuracy, and that test users are unlikely to prefer 
a point-of-care or self-screening test with lower accuracy 
than the tests currently available to them. There was a 
strong preference for remote access to testing, consulta-
tion and antibiotic prescriptions, although for accessing 
a health professional there was no preference between 
online and face-to-face methods. This suggests a remote 
online pathway is acceptable to young people, as long as 
test performance remains equivalent.
In the various hypothetical situations presented, 
respondents showed a preference for chlamydia self-
testing, self-sampling and postal testing over attendance 
at a testing location. For accessing treatment, a general 
preference was exhibited for online versus traditional GP 
or pharmacy services over clinic services. For receipt of 
antibiotics, there was little difference in preferences. We 
were also able to identify which attributes people may be 
willing to trade to maximise their utility. Looking at the 
trade-off between accuracy and time to result, we found 
that young people are willing to wait noticeably longer in 
order to have a test result with a lower chance of a false 
negative result, reinforcing the need for test equivalence.
The strengths of this DCE study include, first, the robust 
methods employed to select attributes and levels, which 
aligned with the recommendations of Coast et al, ensuring 
attributes are ‘manipulable in policy’.38 Second, the fact 
that participants were drawn from the general popula-
tion targeted by the NCSP, rather than from healthcare 
settings. This enabled us to access a demographically and 
geographically representative national sample of young 
people, including those who have had no previous contact 
with STI services. Finally, the use of an online panel 
enabled large-scale data to be collected at a reasonable 
cost and allowed validity checks that would not otherwise 
have been possible with postal questionnaire responses. 
The large sample size also allows comparison between 
several subgroups to explore differences based on age, 
gender, testing history and relationship category.
However, the study does have a few limitations. The first 
relates to the selection of attributes and levels. While the 
selection process employed was very rigorous, this cannot 
detract from the fact that further attributes were identi-
fied which might impact on individuals’ choices. To miti-
gate against this, where such an attribute was excluded, 
information was provided in the survey background 
section to minimise respondents forming their own views 
on the impact of this attribute on the pathway.A
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Use of an online panel also provided accurate records 
of the time taken to complete the survey, and permitted 
additional validity checks which would not otherwise have 
been possible with a written questionnaire. On the other 
hand, use of an online panel excluded young people 
who do not have access to the internet, thereby poten-
tially over-representing the acceptability of online care. 
However, given the extremely high proportion (97%) of 
15–24 year-olds accessing the internet daily via a mobile 
device39 and owning a smartphone,40 it is evident that 
the vast majority of the target population could access 
online care pathways if they choose to do so. The ques-
tion of whether these young people have the degree of 
digital and health literacy needed for online testing and 
treatment was not explored in this study. Finally, informa-
tion was unavailable on young people who opened but 
decided not to complete the questionnaire, so systematic 
comparison with those who responded was not possible.
Behavioural factors, such as embarrassment,7 stigma41 
and privacy and anonymity concerns,42 43 are known to 
influence uptake of sexual health services, as well as struc-
tural factors such as convenience and perceived barriers 
to access8; many of these may be lower for a non-face-to-
face service. Balanced against this, access to online testing 
and treatment is valued less strongly than attributes such 
as test accuracy and time to result. In individual cases, a 
young person’s preference for remote versus face-to-face 
testing and treatment might differ.
Finally, it is difficult to compare the present results 
with other published DCEs because of key differences in 
perspective. Miners et al (sample n=3358)20 and Llewellyn 
et al (sample n=233)21 both only focused on preferences 
within existing traditional service delivery models, and 
did not incorporate any hypothetical future scenarios 
(eg, point-of-care testing, self-testing or treatment via 
eHealth/mHealth solutions). Two other DCE studies, 
which did consider self-sampling at home for chlamydia 
screening,18 19 with sample sizes 174 and 126, respec-
tively, both described sending the sample to a laboratory 
for analysis rather than a self-test. One of these studies19 
did identify a stronger preference for attendance at a 
family planning clinic, rather than self-sampling, but 
since participants were recruited from the waiting room 
of such a clinic they cannot be considered representa-
tive of the general population targeted by the NCSP. A 
fifth study, which examined preferences for point-of-care 
testing, only surveyed clinicians undertaking STI testing 
(sample n=218), thus excluding the population actually 
targeted for chlamydia screening.44 The only stated pref-
erence study that has considered patients’ preferences 
for STI self-testing focused on HIV (sample n=365).45 The 
authors reported results in line with our findings, with 
respondents exhibiting a preference for tests which are 
accurate, timely and private/anonymous. However, this 
study was undertaken in 2002 prior to smartphones and 
at a time when self-testing for HIV was still under devel-
opment. Importantly for screening tests, only one DCE 
study to date21 has sought to include non-service users 
(ie, populations with no experience of STI testing). The 
authors identified a preference for testing for all STIs, 
in settings with healthcare professionals with specialist 
knowledge present, and for receipt of negative as well as 
positive results. This study used a convenience sample of 
233 students from two universities which was unlikely to 
be geographically or socioeconomically representative. 
All other studies have drawn their DCE samples from 
people who were either current service users or attendees 
for other linked services. Use of such samples represents 
a significant shortcoming when considering the intro-
duction of new technologies for asymptomatic chlamydia 
testing and management. Most sample sizes were also 
smaller than in the present study.
A number of questions remain which our research 
does not address. First, recognising that the range of STIs 
included is an important consideration for young people 
in choosing to test,20 21 further research is required to 
understand this better in the context of potential new 
screening pathways which incorporate other STIs (eg, 
gonorrhoea). Second, our study highlights a number of 
methodological considerations where there is an absence 
of consensus that may warrant further exploration to 
improve consistency. These include the number of choice 
sets to include in a DCE and the use of repeated choice 
sets as an internal validity measure. Finally, given that 
cost was not included as an attribute in this study, it is not 
possible to provide an indication of willingness to pay, or 
Table 4 Trade-off between accuracy and time (probability of uptake)
Full data 
set (%) Male (%)
Female 
(%)
16–18 
(%)
19–21 
(%)
22–24 
(%)
Single 
(%)
One 
partner 
(%)
Previous 
test (%)
No 
previous 
test (%)
Pathways:
(n in 100*/time†)
5 in 100*/30 min† 38 40 35 36 39 38 36 39 40 36
2 in 100/14 days 58 55 62 59 58 59 59 58 58 59
Not test 4 5 3 5 3 3 4 3 2 5
Total 100 100 100 100 100 100 100 100 100 100
*Test accuracy=n in 100 people will be told they do not have chlamydia when they do.
†Time to receipt of result.
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the monetary benefits of potential service changes, from 
this DCE.46
The present study is, to our knowledge, the first to 
present a large-scale, quantitative analysis of young 
people’s preferences for attributes of potential new path-
ways to deliver testing and treatment of asymptomatic chla-
mydia, based on a nationally representative population. 
The DCE methodology applied also produced a measure 
of the relative strength of preference between different 
attributes and levels, and potential trade-offs. This can 
provide useful evidence to technology developers, poli-
cymakers, commissioners and service providers. In 
particular, it provides a first insight into preferences for 
the type of technologies currently under development, 
and those which might be available for use in the near 
future, compared with the features of existing products 
and services. This can indicate how young people may 
respond to changes in pathways and to the introduction 
of new technologies.
Within the context of current UK sexual health policy 
and commissioning of sexual health services,12 this DCE 
provides supportive evidence for the policy direction of 
remote chlamydia testing and treatment. However, while 
young people overall expressed a stronger preference 
for attributes such as self-test, online consultation, etc, a 
small proportion still preferred existing pathways. This 
suggests that, in order to maximise benefit, face-to-face 
services should continue to be available in addition to any 
online screening and treatment service. This will ensure 
that services are inclusive and accessible irrespective of 
digital/health literacy, while recognising that people’s 
needs and preferences may change depending on their 
personal circumstances.
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